End-of-day quote
Korea S.E.
18:00:00 2024-06-03 EDT
|
5-day change
|
1st Jan Change
|
2,785
KRW
|
-0.89%
|
|
+6.10%
|
-32.07%
|
Fiscal Period: December |
2022
|
2023
|
---|
Capitalization
1 |
100,986
|
79,583
|
Enterprise Value (EV)
1 |
115,349
|
91,358
|
P/E ratio
|
-5.21
x
|
-4.1
x
|
Yield
|
-
|
-
|
Capitalization / Revenue
|
7.59
x
|
6.16
x
|
EV / Revenue
|
8.67
x
|
7.07
x
|
EV / EBITDA
|
-7.07
x
|
-4.86
x
|
EV / FCF
|
-4.52
x
|
-5.98
x
|
FCF Yield
|
-22.1%
|
-16.7%
|
Price to Book
|
10.8
x
|
10.3
x
|
Nbr of stocks (in thousands)
|
17,717
|
19,410
|
Reference price
2 |
5,700
|
4,100
|
Announcement Date
|
3/23/23
|
3/20/24
|
Fiscal Period: December |
2022
|
2023
|
---|
Net sales
1 |
13,306
|
12,917
|
EBITDA
1 |
-16,317
|
-18,796
|
EBIT
1 |
-17,408
|
-20,572
|
Operating Margin
|
-130.83%
|
-159.26%
|
Earnings before Tax (EBT)
1 |
-17,681
|
-18,792
|
Net income
1 |
-17,681
|
-18,792
|
Net margin
|
-132.88%
|
-145.48%
|
EPS
2 |
-1,095
|
-999.4
|
Free Cash Flow
1 |
-25,492
|
-15,286
|
FCF margin
|
-191.59%
|
-118.34%
|
FCF Conversion (EBITDA)
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
Dividend per Share
|
-
|
-
|
Announcement Date
|
3/23/23
|
3/20/24
|
Fiscal Period: December |
2022
|
2023
|
---|
Net Debt
1 |
14,363
|
11,775
|
Net Cash position
1 |
-
|
-
|
Leverage (Debt/EBITDA)
|
-0.8802
x
|
-0.6265
x
|
Free Cash Flow
1 |
-25,492
|
-15,286
|
ROE (net income / shareholders' equity)
|
-179%
|
-215%
|
ROA (Net income/ Total Assets)
|
-35.3%
|
-33.8%
|
Assets
1 |
50,079
|
55,562
|
Book Value Per Share
2 |
529.0
|
399.0
|
Cash Flow per Share
2 |
281.0
|
364.0
|
Capex
1 |
11,970
|
1,808
|
Capex / Sales
|
89.96%
|
13.99%
|
Announcement Date
|
3/23/23
|
3/20/24
|
|
1st Jan change
|
Capi.
|
---|
| -32.07% | 41M | | +75.69% | 12.57B | | -24.12% | 7.4B | | +10.90% | 6.9B | | +20.88% | 5.79B | | -16.27% | 4.86B | | +19.43% | 4.27B | | -18.62% | 3.96B | | -24.00% | 2.87B | | +52.88% | 2.46B |
Medical Equipment
|